Stock 3341 NIHON CHOUZAI CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials NIHON CHOUZAI Co.,Ltd.

Equities

3341

JP3729200000

Drug Retailers

Delayed Japan Exchange
Other stock markets
 01:04:17 2024-06-04 am EDT 		5-day change 1st Jan Change
1,402 JPY +0.65% Intraday chart for NIHON CHOUZAI Co.,Ltd. +0.79% +0.21%
May. 02 Japanese Shares Muted Amid Firm Yen, Mixed Wall Street MT
May. 02 Nihon Chouzai's Fiscal 2024 Attributable Profit Misses Forecast on Extraordinary Losses MT

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 56,855 49,629 53,527 39,882 34,581 41,675 - -
Enterprise Value (EV) 1 106,416 90,405 92,965 70,511 68,937 76,278 66,662 61,173
P/E ratio 15.4 x 7.41 x 15.1 x 10.8 x 7.76 x 18.6 x 8.92 x 7.43 x
Yield 1.33% 1.51% 1.4% 1.88% 2.16% 1.58% 1.79% 1.91%
Capitalization / Revenue 0.23 x 0.18 x 0.19 x 0.13 x 0.11 x 0.14 x 0.11 x 0.11 x
EV / Revenue 0.43 x 0.34 x 0.33 x 0.24 x 0.22 x 0.22 x 0.18 x 0.16 x
EV / EBITDA 7.33 x 5.84 x 5.71 x 4.71 x 4.22 x 4.18 x 3.85 x 3.16 x
EV / FCF 12.8 x 77.5 x 27 x 6.98 x 38.9 x 11.4 x 13.7 x 9.63 x
FCF Yield 7.82% 1.29% 3.71% 14.3% 2.57% 8.78% 7.31% 10.4%
Price to Book 1.37 x 0.53 x 1.07 x 0.75 x 0.61 x 0.81 x 0.67 x 0.61 x
Nbr of stocks (in thousands) 30,323 29,987 29,987 29,987 29,914 29,917 - -
Reference price 2 1,875 1,655 1,785 1,330 1,156 1,393 1,393 1,393
Announcement Date 4/26/19 4/30/20 4/30/21 4/28/22 4/28/23 4/30/24 - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 245,687 268,520 278,951 299,392 313,318 340,310 368,329 388,970
EBITDA 1 14,524 15,490 16,285 14,972 16,337 18,251 17,300 19,370
EBIT 1 6,733 7,593 8,106 6,589 7,586 9,142 8,373 9,967
Operating Margin 2.74% 2.83% 2.91% 2.2% 2.42% 2.69% 2.27% 2.56%
Earnings before Tax (EBT) 1 6,777 11,885 6,483 6,217 7,843 5,137 7,940 9,534
Net income 1 3,790 6,697 3,538 3,705 4,458 2,553 4,671 5,612
Net margin 1.54% 2.49% 1.27% 1.24% 1.42% 0.75% 1.27% 1.44%
EPS 2 121.7 223.3 118.0 123.6 148.9 85.35 156.1 187.6
Free Cash Flow 1 8,318 1,167 3,446 10,098 1,771 6,695 4,871 6,352
FCF margin 3.39% 0.43% 1.24% 3.37% 0.57% 1.97% 1.32% 1.63%
FCF Conversion (EBITDA) 57.27% 7.53% 21.16% 67.45% 10.84% 36.68% 28.16% 32.79%
FCF Conversion (Net income) 219.47% 17.43% 97.4% 272.55% 39.73% 262.24% 104.27% 113.18%
Dividend per Share 2 25.00 25.00 25.00 25.00 25.00 25.00 25.00 26.67
Announcement Date 4/26/19 4/30/20 4/30/21 4/28/22 4/28/23 4/30/24 - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2020 S1 2021 S1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 S1 2025 Q3 2025 Q4
Net sales 1 130,297 135,999 74,351 146,202 77,237 75,953 74,709 77,622 152,331 80,513 80,474 81,848 84,462 166,310 87,817 86,183 90,225 92,024 181,800 96,225 94,526
EBITDA - - - - - - - - - - - - - - - - - - - - -
EBIT 1 4,066 2,774 1,480 2,416 3,411 762 892 1,921 2,813 3,016 1,757 1,596 1,801 3,397 3,153 2,592 1,000 1,850 2,600 2,450 2,200
Operating Margin 3.12% 2.04% 1.99% 1.65% 4.42% 1% 1.19% 2.47% 1.85% 3.75% 2.18% 1.95% 2.13% 2.04% 3.59% 3.01% 1.11% 2.01% 1.43% 2.55% 2.33%
Earnings before Tax (EBT) 3,745 2,662 1,359 2,352 -313 - 925 1,925 2,850 4,110 883 1,605 - 3,378 3,090 - - - - - -
Net income 1 2,094 1,555 913 1,340 -244 2,609 391 1,216 1,607 2,682 169 659 1,089 1,748 2,021 -1,216 414 1,238 1,404 1,550 1,148
Net margin 1.61% 1.14% 1.23% 0.92% -0.32% 3.44% 0.52% 1.57% 1.05% 3.33% 0.21% 0.81% 1.29% 1.05% 2.3% -1.41% 0.46% 1.35% 0.77% 1.61% 1.21%
EPS 69.86 51.89 - 44.71 -8.140 - 13.05 - 53.66 89.57 - 22.06 - 58.44 67.55 - - - - - -
Dividend per Share 12.50 12.50 - 12.50 - - - - 12.50 - - - - 12.50 - - - - - - -
Announcement Date 10/31/19 10/30/20 10/29/21 10/29/21 1/31/22 4/28/22 7/29/22 10/31/22 10/31/22 1/31/23 4/28/23 7/31/23 10/31/23 10/31/23 1/31/24 4/30/24 - - - - -
1JPY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 49,561 40,776 39,438 30,629 34,356 28,889 24,987 19,498
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 3.412 x 2.632 x 2.422 x 2.046 x 2.103 x 1.583 x 1.444 x 1.007 x
Free Cash Flow 1 8,318 1,167 3,446 10,098 1,771 6,695 4,871 6,352
ROE (net income / shareholders' equity) 9.2% 15.2% 7.3% 7.2% 8.2% 4.4% 7.7% 8.6%
ROA (Net income/ Total Assets) 3.33% 4.07% 4.52% 3.71% 4.22% 4.96% 3.9% 4.07%
Assets 1 113,897 164,702 78,218 99,925 105,632 51,442 119,778 138,008
Book Value Per Share 2 1,370 3,140 1,663 1,763 1,888 1,950 2,071 2,266
Cash Flow per Share 329.0 879.0 337.0 348.0 378.0 328.0 - -
Capex 1 5,254 5,624 5,955 8,114 10,321 12,188 7,600 7,767
Capex / Sales 2.14% 2.09% 2.13% 2.71% 3.29% 3.58% 2.06% 2%
Announcement Date 4/26/19 4/30/20 4/30/21 4/28/22 4/28/23 4/30/24 - -
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for NIHON CHOUZAI Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
1,393 JPY
Average target price
1,580 JPY
Spread / Average Target
+13.42%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Retail - Drugs without Grocery

1st Jan change Capi.
NIHON CHOUZAI CO.,LTD. Stock NIHON CHOUZAI Co.,Ltd.
0.00% 264M
RAIA DROGASIL S.A. Stock Raia Drogasil S.A.
-14.35% 8.2B
AIN HOLDINGS INC. Stock Ain Holdings Inc.
+30.96% 1.3B
QOL HOLDINGS CO., LTD. Stock Qol Holdings Co., Ltd.
-9.29% 354M
SALUS, LJUBLJANA, D. D. Stock SALUS, Ljubljana, d. d.
+11.11% 229M
GREEN CROSS HEALTH LIMITED Stock Green Cross Health Limited
-10.09% 86.36M
MEDICAL IKKOU GROUP CO.,LTD. Stock Medical Ikkou Group Co.,Ltd.
+29.91% 61.19M
Retail - Drugs without Grocery
  1. Stock Market
  2. Equities
  3. 3341 Stock
  4. Financials NIHON CHOUZAI Co.,Ltd.